232 related articles for article (PubMed ID: 12067866)
21. An optimal dose study of intrathecal morphine in gynecological patients.
Rodanant O; Sirichotewithayakorn P; Sriprajittichai P; Charuluxananan S
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S331-7. PubMed ID: 12930007
[TBL] [Abstract][Full Text] [Related]
22. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
23. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
24. Drug-related side effects of long-term intrathecal morphine therapy.
Ruan X
Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
[TBL] [Abstract][Full Text] [Related]
25. High-dose intrathecal morphine to control cancer pain--a case report.
Tamakawa S; Iwanami Y; Ogawa H
J Pain Symptom Manage; 1998 Jan; 15(1):70-2. PubMed ID: 9436341
[TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
[TBL] [Abstract][Full Text] [Related]
27. [Long-term treatment with intrathecal morphine in severe painful cancer].
Eriksen K; Bigler D; Jensen NH; Eriksen J
Ugeskr Laeger; 1989 Sep; 151(37):2365-6. PubMed ID: 2477927
[TBL] [Abstract][Full Text] [Related]
28. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
Liu HJ; Gao XZ; Liu XM; Xia M; Li WY; Jin Y
J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571
[TBL] [Abstract][Full Text] [Related]
29. Intracerebroventricular morphine for refractory cancer pain: transitioning to the home setting.
Adolph MD; Stretanski MF; McGregor JM; Rawn BL; Ross PM; Benedetti C
Am J Hosp Palliat Care; 2010 Aug; 27(5):326-32. PubMed ID: 20103784
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
[TBL] [Abstract][Full Text] [Related]
31. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer.
Gestin Y; Vainio A; Pégurier AM
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 1):12-7. PubMed ID: 9061109
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
[TBL] [Abstract][Full Text] [Related]
33. [Role of continuous intravenous infusion of morphine in the cancer pain relieving therapy].
Kato Y; Kato A
Nihon Rinsho; 2001 Sep; 59(9):1789-93. PubMed ID: 11554053
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
Anderson VC; Burchiel KJ
Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
[TBL] [Abstract][Full Text] [Related]
36. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain.
Yang CY; Wong CS; Chang JY; Ho ST
Can J Anaesth; 1996 Apr; 43(4):379-83. PubMed ID: 8697554
[TBL] [Abstract][Full Text] [Related]
37. Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer.
Sandouk P; Serrie A; Urtizberea M; Debray M; Got P; Scherrmann JM
Clin Pharmacol Ther; 1991 Apr; 49(4):442-8. PubMed ID: 2015734
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal morphine for neuropathic pain in a pregnant cancer patient.
Wen YR; Hou WY; Chen YA; Hsieh CY; Sun WZ
J Formos Med Assoc; 1996 Mar; 95(3):252-4. PubMed ID: 8857260
[TBL] [Abstract][Full Text] [Related]
39. Movement-evoked breakthrough cancer pain despite intrathecal analgesia: a prospective series.
Bäckryd E; Larsson B
Acta Anaesthesiol Scand; 2011 Oct; 55(9):1139-46. PubMed ID: 22092213
[TBL] [Abstract][Full Text] [Related]
40. Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance?
Sallerin-Caute B; Lazorthes Y; Deguine O; Francés B; Verdié JC; Charlet JP; Bastide R
Neurosurgery; 1998 Jan; 42(1):44-9; discussion 49-50. PubMed ID: 9442502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
